Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Rheumatoid Arthritis

The Key to Early Rheumatoid Arthritis

Annette H.M. van der Helm-van Mil, MD, PhD, and Tom W.J. Huizinga, MD, PhD  |  

The conundrum of classification versus diagnosis

Our Commitment to Research

Stanley B. Cohen, MD  |  

The ACR has a wide range of programs to support investigations in rheumatology

Within Our Reach: Collaborating to Find a Cure for RA

David R. Karp, MD, PhD  |  

Research is critically important to find cures and accelerate patient care for the millions who suffer from arthritis and rheumatic disease. Despite its prevalence in the population and recent treatment advances, rheumatoid arthritis (RA) remains an incurable disease and receives disproportionately less research funding from federal sources than most other autoimmune diseases. This is precisely why the ACR Research and Education Foundation (REF) launched Within Our Reach: Finding a Cure for Rheumatoid Arthritis to directly invest in the types of innovative research not being done elsewhere in the country.

Recent Study Improves Understanding of Preclinical Rheumatoid Arthritis

  |  

A study recently published in Arthritis Care & Research (AC&R) reveals a novel approach for the study of preclinical rheumatoid arthritis (RA). The investigators conducting the study sought to determine if these RA-related biomarkers could also be found in healthy subjects in order to investigate relationships between genetic and environmental factors and the presence of these biomarkers. Their goal is to study how these biomarkers evolve.